576 related articles for article (PubMed ID: 34234641)
21. Increased Neurofilament Light Chain and YKL-40 CSF Levels in One Japanese IBMPFD Patient With VCP R155C Mutation: A Clinical Case Report With CSF Biomarker Analyses.
Ikeda M; Kuwabara T; Takai E; Kasahara H; Furuta M; Sekine A; Makioka K; Yamazaki T; Fujita Y; Nagashima K; Higuchi T; Tsushima Y; Ikeda Y
Front Neurol; 2020; 11():757. PubMed ID: 32849216
[TBL] [Abstract][Full Text] [Related]
22. CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression.
Sun Q; Zhao X; Li S; Yang F; Wang H; Cui F; Huang X
Front Neurol; 2020; 11():919. PubMed ID: 32982935
[No Abstract] [Full Text] [Related]
23. Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes.
Pijnenburg YA; Verwey NA; van der Flier WM; Scheltens P; Teunissen CE
Alzheimers Dement (Amst); 2015 Dec; 1(4):505-12. PubMed ID: 27239528
[TBL] [Abstract][Full Text] [Related]
24. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.
Karantali E; Kazis D; Chatzikonstantinou S; Petridis F; Mavroudis I
Aging Clin Exp Res; 2021 Apr; 33(4):869-881. PubMed ID: 32306372
[TBL] [Abstract][Full Text] [Related]
25. CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration.
Pawlitzki M; Schreiber S; Bittner D; Kreipe J; Leypoldt F; Rupprecht K; Carare RO; Meuth SG; Vielhaber S; Körtvélyessy P
Front Neurol; 2018; 9():1037. PubMed ID: 30631300
[No Abstract] [Full Text] [Related]
26. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431
[TBL] [Abstract][Full Text] [Related]
27. Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion.
Benatar M; Wuu J; Andersen PM; Lombardi V; Malaspina A
Ann Neurol; 2018 Jul; 84(1):130-139. PubMed ID: 30014505
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
[TBL] [Abstract][Full Text] [Related]
29. Neurofilament light chain: a biomarker for genetic frontotemporal dementia.
Meeter LH; Dopper EG; Jiskoot LC; Sanchez-Valle R; Graff C; Benussi L; Ghidoni R; Pijnenburg YA; Borroni B; Galimberti D; Laforce RJ; Masellis M; Vandenberghe R; Ber IL; Otto M; van Minkelen R; Papma JM; Rombouts SA; Balasa M; Öijerstedt L; Jelic V; Dick KM; Cash DM; Harding SR; Jorge Cardoso M; Ourselin S; Rossor MN; Padovani A; Scarpini E; Fenoglio C; Tartaglia MC; Lamari F; Barro C; Kuhle J; Rohrer JD; Teunissen CE; van Swieten JC
Ann Clin Transl Neurol; 2016 Aug; 3(8):623-36. PubMed ID: 27606344
[TBL] [Abstract][Full Text] [Related]
30. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
[TBL] [Abstract][Full Text] [Related]
31. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
[TBL] [Abstract][Full Text] [Related]
32. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and Prognostic Performance of Neurofilaments in ALS.
Poesen K; Van Damme P
Front Neurol; 2018; 9():1167. PubMed ID: 30713520
[TBL] [Abstract][Full Text] [Related]
34. CSF neurofilament light chain reflects corticospinal tract degeneration in ALS.
Menke RA; Gray E; Lu CH; Kuhle J; Talbot K; Malaspina A; Turner MR
Ann Clin Transl Neurol; 2015 Jul; 2(7):748-55. PubMed ID: 26273687
[TBL] [Abstract][Full Text] [Related]
35. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
Kasai T; Kojima Y; Ohmichi T; Tatebe H; Tsuji Y; Noto YI; Kitani-Morii F; Shinomoto M; Allsop D; Mizuno T; Tokuda T
Ann Clin Transl Neurol; 2019 Dec; 6(12):2489-2502. PubMed ID: 31742901
[TBL] [Abstract][Full Text] [Related]
36. Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain.
Gaetani L; Parnetti L; Calabresi P; Di Filippo M
Front Neurosci; 2021; 15():672954. PubMed ID: 34108859
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis.
Yang B; Wu Y; Wang Y; Yang H; Du B; Di W; Xu X; Shi X
Neurol Sci; 2020 Oct; 41(10):2915-2920. PubMed ID: 32338335
[TBL] [Abstract][Full Text] [Related]
38. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.
Verde F; Steinacker P; Weishaupt JH; Kassubek J; Oeckl P; Halbgebauer S; Tumani H; von Arnim CAF; Dorst J; Feneberg E; Mayer B; Müller HP; Gorges M; Rosenbohm A; Volk AE; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):157-164. PubMed ID: 30309882
[TBL] [Abstract][Full Text] [Related]
39. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.
Poesen K; De Schaepdryver M; Stubendorff B; Gille B; Muckova P; Wendler S; Prell T; Ringer TM; Rhode H; Stevens O; Claeys KG; Couwelier G; D'Hondt A; Lamaire N; Tilkin P; Van Reijen D; Gourmaud S; Fedtke N; Heiling B; Rumpel M; Rödiger A; Gunkel A; Witte OW; Paquet C; Vandenberghe R; Grosskreutz J; Van Damme P
Neurology; 2017 Jun; 88(24):2302-2309. PubMed ID: 28500227
[TBL] [Abstract][Full Text] [Related]
40. Emerging perspectives of synaptic biomarkers in ALS and FTD.
Krishnamurthy K; Pradhan RK
Front Mol Neurosci; 2023; 16():1279999. PubMed ID: 38249293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
